Viral Hepatitis clinical trials at UCSF

1 in progress, 0 open to eligible people

Tobevibart + Elebsiran in Chronic HDV Infection
Sorry, in progress, not accepting new patients
This is a multicenter, open label, randomized Phase 3 clinical study to evaluate the efficacy and safety of the combination of tobevibart + elebsiran for the treatment of chronic hepatitis delta in comparison to delayed treatment.
San Francisco, California and other locations

Last updated: November 12, 2025